Eos BioInnovation is leveraging current advancements and breakthroughs in cell, gene, and tissue therapies across the regenerative medicine value chain that will fundamentally alter healthcare. In lieu of daily “maintenance medicines,” regenerative medicine aims to cure the root causes of disease and provide treatments for the most challenging diseases and conditions across a variety of treatment modalities. An investment in Eos is an investment in the promise of curative therapies and cutting-edge technologies developed, vetted, and built by world leading experts.